About Biocorp
Biocorp is a Healthcare company based in Issoire (France) founded in 2004, and was acquired by Novo Nordisk in June 2023. Drug delivery systems and medical devices are developed and manufactured. Biocorp offers products and services including Dispositifs connectés and Dispositifs pharmaceutiques. Its focus areas include Life Sciences, Drug Delivery and Intravenous.
Company details
Founded in 2004, operations are based in Issoire, France, within the pharmaceutical and medical device sector. Drug delivery systems, such as the Newguard Passive Safety System for pre-filled syringes, are produced alongside wireless-enabled devices including the DataPen smart injector, EasyLog sensors for injectors, and InsPair sensors for inhalers. Manufacturing services encompass injection molding, assembly, and packaging, with focus on supply chain and cost efficiencies.
- Headquarters Issoire, France
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biocorpsys.com
- Social LinkedIn X
- Acquired by Novo Nordisk (Jun 2023)
- Investors
- Acquired byNovo Nordisk
(Jun 2023)
Products & Services of Biocorp
Biocorp offers a comprehensive portfolio of products and services, including Dispositifs connectés and Dispositifs pharmaceutiques.
Devices for monitoring and improving patient care in healthcare.
Pharmaceutical tools for drug delivery and management systems.
Investors in Biocorp
Biocorp has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novo Nordisk.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured. | 1923 | novonordisk.com | Bagsvaerd, Denmark |
Investor details for Biocorp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biocorp
3 dated milestones of Biocorp across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Biocorp is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Novo Nordisk.
Web traffic of Biocorp
The website of Biocorp (biocorpsys.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 8.3% vs previous month
Websites whose visitors overlap most with Biocorp. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tolomei.fr | tolomei.fr | 100% | #5,375,818 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biocorp
Complete news archive for Biocorp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocorp
Biocorp was founded in 2004.
Biocorp is headquartered in Issoire, France. It is registered at Issoire, Auvergne-rhone-alpes, France.
Founded in 2004, operations are based in Issoire, France, within the pharmaceutical and medical device sector. Drug delivery systems, such as the Newguard Passive Safety System for pre-filled syringes, are produced alongside wireless-enabled devices including the DataPen smart injector, EasyLog sensors for injectors, and InsPair sensors for inhalers. Manufacturing services encompass injection molding, assembly, and packaging, with focus on supply chain and cost efficiencies.
Biocorp offers Dispositifs connectés and Dispositifs pharmaceutiques.
Biocorp has 1 investor. Key investors include Novo Nordisk.
Yes. Biocorp was acquired by Novo Nordisk in June 2023.

